Scalp Soothing

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Scalp Soothing
Generic name: PIROCTONE OLAMINE
Manufacturer: Guangdong Outeli Biotechnology Co., Ltd
Product type: HUMAN OTC DRUG
SPL set ID: 57313605-16a5-736a-e063-6394a90a1924
SPL ID: 57313605-16a6-736a-e063-6394a90a1924
Version: 1
Effective date: 2026-07-22
Source export date: 2026-10-12
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/edd23646015c9adc800cdbe2b778398a2d2b70e90dce5721ef2b191499a0397f/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:56:32

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		505G(a)(3)	openfda.application_number
brand name		Scalp Soothing	openfda.brand_name
generic name		PIROCTONE OLAMINE	openfda.generic_name
manufacturer name		Guangdong Outeli Biotechnology Co., Ltd	openfda.manufacturer_name
ndc	package	87765-002-01	openfda.package_ndc
ndc	product	87765-002	openfda.product_ndc
ndc11	package	87765000201	derived:openfda.package_ndc
rxcui		2747676	openfda.rxcui
spl id		57313605-16a6-736a-e063-6394a90a1924	id
spl set id		57313605-16a5-736a-e063-6394a90a1924	set_id
unii		A4V5C6R9FB	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

·For externaluse only. ·Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water. Discontinue use if irritation or rash develops and consult a doctor. ·Keep out of reach of children. If swallowed, get medical help or contact ·a Poison Control Center right away. Avoid inhaling powder.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.